HPA-1a/1b could be considered a molecular predictor of poor prognosis in chronic hepatitis C.
HPA polymorphism has been associated with HCV presence and fibrosis progression in chronic hepatitis C. However, it is unknown if there is an association between HPA-1 polymorphism and hepatocellular carcinoma (HCC). Therefore, this study aimed to evaluate HPA-1 polymorphism in the presence of HCC. PCR-SSP was used to perform HPA genotyping on 76 HCV-infected patients. There was no association between patients with and without HCC. There was significant difference in HPA-1 genotypic frequency distribution between HCC and F1/F2 fibrosis degree. The HPA-1a/1b polymorphism appears to be more associated with liver damage progression than with HCC presence.